NY-ESO-1 (CTAG1B) expression in mesenchymal tumors-Reference-Cited by-同舟云学术

NY-ESO-1 (CTAG1B) expression in mesenchymal tumors

Published:2014-11-21 Issue:4 Volume:28 Page:587-595
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Endo Makoto,de Graaff Marieke A,Ingram Davis R,Lim Simin,Lev Dina C,Briaire-de Bruijn Inge H,Somaiah Neeta,Bovée Judith VMG,Lazar Alexander J,Nielsen Torsten O

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/modpathol2014155.pdf

Reference32 articles.

1. Chen YT, Scanlan MJ, Sahin U et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci U S A 1997;94:1914–1918.

2. Jungbluth AA, Chen YT, Stockert E et al. Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 2001;92:856–860.

3. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT . Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002;188:22–32.

4. Nicholaou T, Ebert L, Davis ID et al. Directions in the immune targeting of cancer: lessons learned from the cancer-testis Ag NY-ESO-1. Immunol Cell Biol 2006;84:303–317.

5. Robbins PF, Morgan RA, Feldman SA et al. Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 2011;29:917–924.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NY‐ESO‐1 antigen: A promising frontier in cancer immunotherapy;Clinical and Translational Medicine;2024-09

2. Investigating the prognostic impact of NY-ESO-1 expression and HLA subtypes in metastatic synovial sarcoma;ESMO Open;2024-08

3. Histological Assessment of Synovial Sarcoma Before and After TCR-T Cell Therapy and Cryoablation: A Case Report;Anticancer Research;2023-11-29

4. Gene of the month: cancer testis antigen gene 1b (NY-ESO-1);Journal of Clinical Pathology;2023-10-19

5. Safety and Efficacy of NY-ESO-1 Antigen-Specific T-Cell Receptor Gene-Transduced T Lymphocytes in Patients with Synovial Sarcoma: A Phase I/II Clinical Trial;Clinical Cancer Research;2023-10-04